Breadcrumb

[A05-03] Long-acting insulin analogues in the treatment of diabetes mellitus type 2

Overview

Overview

Commission: Commission awarded on 2005-02-22 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of the final report  [PDF, 87 kB]Further documents
Contact address:to the contact form

Report documents

Report documents

PublishedDocumentSizeType 
2009-03-19 Executive summary of the final report 87 kBPDFdownload file
2009-03-19 Final report (German version) 3 MBPDFdownload file
2009-03-19 Documentation and appraisal of comments on the preliminary report (German version) 24 MBPDFdownload file
2008-03-28 Preliminary report (German version) 2 MBPDFdownload file
2008-01-29 Report plan version 2.0 (German version) 197 kBPDFdownload file
2008-01-29 Documentation and appraisal of comments on the report plan version 1.0 (German version) 7 MBPDFdownload file
2007-06-28 Amendment 1 to the report plan version 1.0 (German version) 78 kBPDFdownload file
2005-10-18 Report plan version 1.0 (German version) 76 kBPDFdownload file


At a glance

Accompanying information

Executive summary of the final report

  File-Icon  Long-acting insulin analogues in the treatment of diabetes mellitus type 2 [PDF, 87 kB]

Health information

Further information for consumers and patients on this topic is provided on IQWiG's health information website InformedHealthOnline.org:

Medication for type 2 diabetes

Press releases

2009-03-19 Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close